Full Text:   <302>

CLC number: 

On-line Access: 2024-08-27

Received: 2023-10-17

Revision Accepted: 2024-05-08

Crosschecked: 0000-00-00

Cited: 0

Clicked: 592

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE  Vol. No. P.

http://doi.org/10.1007/s42242-BDMJ-D-23-00285


3D Bioprinting Tumor Models and their Application Progress


Author(s):  Huaixu Li, Yang Qiao, Xingliang Dai, Haotian Tian, Zhenyu Han, Sheng Cheng, Peng Gao, Hongwei Cheng

Affiliation(s):  Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei 230001, China; more

Corresponding email(s):   hongwei.cheng@ahmu.edu.cn, gaopeng@ahmu.edu.cn, daixingliang@ahmu.edu.cn

Key Words:  Bioprinting, TME, Cancer model, Application


Huaixu Li,Yang Qiao,Xingliang Dai,Haotian Tian,Zhenyu Han,Sheng Cheng,Peng Gao,Hongwei Cheng. 3D Bioprinting Tumor Models and their Application Progress[J]. Journal of Zhejiang University Science , , (): .

@article{title="3D Bioprinting Tumor Models and their Application Progress",
author="Huaixu Li,Yang Qiao,Xingliang Dai,Haotian Tian,Zhenyu Han,Sheng Cheng,Peng Gao,Hongwei Cheng",
journal="Journal of Zhejiang University Science ",
volume="",
number="",
pages="",
year="",
publisher="Zhejiang University Press & Springer",
doi="10.1007/s42242-BDMJ-D-23-00285"
}

%0 Journal Article
%T 3D Bioprinting Tumor Models and their Application Progress
%A Huaixu Li
%A Yang Qiao
%A Xingliang Dai
%A Haotian Tian
%A Zhenyu Han
%A Sheng Cheng
%A Peng Gao
%A Hongwei Cheng
%J Journal of Zhejiang University SCIENCE
%V
%N
%P
%@ 1673-1581
%D
%I Zhejiang University Press & Springer
%DOI 10.1007/s42242-BDMJ-D-23-00285

TY - JOUR
T1 - 3D Bioprinting Tumor Models and their Application Progress
A1 - Huaixu Li
A1 - Yang Qiao
A1 - Xingliang Dai
A1 - Haotian Tian
A1 - Zhenyu Han
A1 - Sheng Cheng
A1 - Peng Gao
A1 - Hongwei Cheng
J0 - Journal of Zhejiang University Science
VL -
IS -
SP -
EP -
%@ 1673-1581
Y1 -
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1007/s42242-BDMJ-D-23-00285


Abstract: 
The most common cause of mortality in people is cancer, which has turned into an unbridgeable health gap because of its unrestrained aberrant proliferation, quick growth, metastasis, and high heterogeneity. Conventional two-dimensional cell culture models along with animal models for tumor diagnostic and therapeutic studies have extremely low clinical translation rates due to their intrinsic limitations. Appropriate tumor models are required for cancer research. Engineered human 3D cancer models are better able to replicate the spatial organization, cellular resources, and tumor microenvironment features (hypoxia, necrosis, and delayed proliferation) of the actual human tumor microenvironment. Emerging technology known as 3D bioprinting makes it possible to fabricate live structures by precisely regulating the spatial distribution of cells, biomolecules, and matrix components. The aim of this paper is to review the current technology and bioink of 3D bioprinted cancer models, including glioma, breast, liver, intestinal, cervical, ovarian, and neuroblastoma models, as well as the advances in their applications in the fields of tumor microenvironment, tumor vascularization, tumor stem cells, tumor resistance and drug screening, tumor immunotherapy, and precision medicine.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE